Clinical Trial Update: Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC) [Phase 2]

View source ↗

Summary

A Phase 2 study of the novel epothilone BMS-247550 in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• BMS-247550 (epothilone B) (epothilone B)

Snippet

Sponsor: R-Pharm | Conditions: Breast Cancer, Metastases | Phase 2 | Status: COMPLETED